SEC Form 4 · accession 0001209191-15-086708
OTONOMY, INC. · OTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl LeBel
Officer — Chief Scientific Officer
Period of report
Dec 21, 2015
Accepted (ET)
Dec 22, 2015 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001493566
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2015 | M | 16,576 | $6.33 | A | 25,496 | D | |
| Common Stock | Dec 21, 2015 | M | 4,674 | $3.17 | A | 30,170 | D | |
| Common StockF2 | Dec 21, 2015 | S | 13,189 | $27.8318 | D | 16,981 | D | |
| Common StockF3 | Dec 21, 2015 | S | 8,061 | $28.3778 | D | 8,920 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F5,F4 | $6.33 | Dec 21, 2015 | M | 16,576 | D | — | Jun 30, 2024 | Common Stock | 16,576 | 51,380 | D |
| Employee stock option (right to buy)F5,F6 | $3.17 | Dec 21, 2015 | M | 4,674 | D | — | Nov 19, 2020 | Common Stock | 4,674 | 25,189 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The sale price reported in Column 4 of Table I represents the weighted average sale price of the shares sold ranging from $27.22 to $28.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F3The sale price reported in Column 4 of Table I represents the weighted average sale price of the shares sold ranging from $28.22 to $29.04 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F4One-fourth of the shares subject to the option vested on April 23, 2015 and one forty-eighth of the shares vest monthly thereafter.
- F5In addition to the options to purchase 21,250 shares of common stock as set forth in Table II, the Reporting Person currently holds options to purchase up to an aggregate of 280,781 shares of common stock, which options vest according to their terms.
- F6One-fourth of the shares subject to the option vested on November 19, 2011 and one forty-eighth of the shares vested monthly thereafter.